In a Phase IIa study for MASH, subjects treated with the drug experienced a 2.3% weight loss over three months, accompanied ...

However, recent data show that adipocytokines, especially adiponectin, exert various functions throughout the organism that are neither unambiguously protective nor solely harmful. In a study ...